Sharon Bio-Medicine Ltd-$ (Delisted) share news and announcements

BSE: 532908Pharmaceuticals & Biotechnology

Last traded ₹3.30 on 28 Mar 2019

Delisted on 20 Feb 2024.

Last results date

The last board meeting held for results; the company has not yet given notice of the next.Sharon Bio-Medicine Ltd-$ quarterly results

May30Tue

The board met on 30 May 2023 to consider audited results and financial results

Notice filed 23 May 2023

Declaration of Audited Financial Results for the quarter and year ended March 31, 2023 (opens in a new tab)

Sharon Bio-Medicine Ltd-$ annual reports, presentations and earnings calls

The company's own documents, latest first.Sharon Bio-Medicine Ltd-$ financials, year by year

Annual reports16

Annual report, year to Mar 2016 (opens in a new tab)27 Sep 2016
Annual report, year to Jun 2015 (opens in a new tab)4 Dec 2015
Annual report, year to Jun 2014 (opens in a new tab)15 Sep 2015
Annual report, year to Jun 2013 (opens in a new tab)15 Jan 2014
Annual report, year to Jun 2012 (opens in a new tab)18 Mar 2013

11 earlier reports

Annual report, year to Mar 2011 (opens in a new tab)Filing day not known
Annual report, year to Jun 2010 (opens in a new tab)Filing day not known
Annual report, year to Mar 2009 (opens in a new tab)Filing day not known
Annual report, year to Mar 2008 (opens in a new tab)Filing day not known
Annual report, year to Mar 2007 (opens in a new tab)Filing day not known
Annual report, year to Mar 2006 (opens in a new tab)Filing day not known
Annual report, year to Mar 2005 (opens in a new tab)Filing day not known
Annual report, year to Mar 2004 (opens in a new tab)Filing day not known
Annual report, year to Mar 2003 (opens in a new tab)Filing day not known
Annual report, year to Mar 2002 (opens in a new tab)Filing day not known
Annual report, year to Mar 2001 (opens in a new tab)Filing day not known

Sharon Bio-Medicine Ltd-$ share news and announcements

831 announcements, routine notices left out, newest first. Page 1 of 17.

Feb 2024
- 14 Feb · Delisting
  Members of the Exchange are hereby informed that the admission to dealings in securities of Sharon Bio-Medicine Limited shall be withdrawn (delisted) w.e.f. February 20, 2024 pursuant to the Resolution Plan approved by the Hon'ble Mumbai Bench of National Company Law Tribunal (NCLT) under Section 31 of the Insolvency and Bankruptcy Code (IBC), 2016.
Aug 2023
- 25 Aug · Legal
  Exchange had sought clarification from Sharon Bio-Medicine Limited with respect to announcement dated 27-Feb-2023, regarding fire accident at the Company's manufacturing unit located at M/s Sharon Bio-Medicine Limited, Plot No L6, MIDC Area, Taloja, Panvel, Dist: Raigad, Maharashtra. On basis of above the Company was required to clarify following: 1. Insurance amount claimed and realized by the listed entity for the loss/damage; 2. The actual amount of damage caused due to the natural calamity or other force majeure events; 3. Details of steps taken to restore normalcy and the impact of the natural calamity/other force majeure events on production or service, financials of the entity. The response of the Company is attached. (opens in a new tab)
Jun 2023
- 30 Jun · Corporate Insolvency Resolution Process
  Intimation regarding successful implementation of the Approved Resolution Plan (opens in a new tab)
- 30 Jun · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
  Intimation regarding successful implementation of the Approved Resolution Plan (opens in a new tab)
- 16 Jun · Legal
  Exchange has sought clarification from Sharon Bio-Medicine Limited for the quarter ended 31-Mar-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not signed by authorized signatory/ies -2. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is awaited.
- 8 Jun · Suspension of Trading
  Members of the Exchange are hereby informed that the trading in equity shares of Sharon Bio-Medicine Limited (ISIN: INE028B01029) shall continue to be suspended pursuant to order dated May 17, 2023 passed by National Company Law Tribunal.
May 2023
- 30 May · Results
  Financial results for the period ended March 31, 2023. (opens in a new tab)
- 30 May · Board meeting
  Board meeting held on May 30, 2023. (opens in a new tab)
- 30 May · Board meeting
  This is to inform you that the Monitoring Committee has today i.e.,Tuesday, May 30, 2023, inter alia, considered and approved the Audited Financial Results for the quarter and year ended .... (opens in a new tab)
- 30 May · Corporate action
  Pursuant to the provisions of Regulation 42 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 and Para 7E of the Order dated May 17, 2023 passed by the Hon'ble NCLT, .... (opens in a new tab)
- 30 May · Corporate action
  Record date for the purpose of Delisting of Shares pursuant to NCLT Order dated 17th May 2023 is 09-Jun-2023. (opens in a new tab)
- 23 May · Board meeting
  Declaration of Audited Financial Results for the quarter and year ended March 31, 2023 (opens in a new tab)
- 23 May · Board meeting
  SHARON BIO-MEDICINE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve Pursuant to Regulation .... (opens in a new tab)
- 19 May · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
  Constitute of Monitoring Committee pursuant to the Order of NCLT dated 17th May 2013 (opens in a new tab)
- 19 May · Corporate Insolvency Resolution Process
  Intimation regarding Monitoring Committee pursuant to the order of NCLT dated 17th May 2023 (opens in a new tab)
- 19 May · Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal
  Hon'ble NCLT, Mumbai Bench on May 17, 2023, has pronounced its orders approving the resolution plan by allowing the application seeking approval of the resolution plan of Innova Captab .... (opens in a new tab)
- 19 May · Corporate Insolvency Resolution Process
  Intimation about the Approval of Resolution Plan (opens in a new tab)
- 17 May · Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal
  This intimation is in reference to the captioned matter and in furtherance to our earlier corporate announcements made vide letters dated April 22, 2023 and November 23, 2022, wherein, .... (opens in a new tab)
- 17 May · Corporate Insolvency Resolution Process
  Intimation regarding Approval of Resolution Plan by Hon'ble NCLT (opens in a new tab)
Apr 2023
Mar 2023
- 27 Mar · Legal
  Exchange had sought clarification from Sharon Bio-Medicine Limited with respect to announcement dated 18-Feb-2023, regarding strikes/lockouts/disturbances. On basis of above the Company was required to clarify following: 1. In the event of settlement of the proceedings, details of such settlement including - terms of the settlement, compensation/penalty paid (if any) and impact of such settlement on the financial position of the listed entity.The response of the Company is attached. (opens in a new tab)
- 16 Mar · Legal
  Exchange has sought clarification from Sharon Bio-Medicine Limited with respect to announcement dated 27-Feb-2023, regarding fire accident at the Company's manufacturing unit located at M/s Sharon Bio-Medicine Limited, Plot No L6, MIDC Area, Taloja, Panvel, Dist: Raigad, Maharashtra. On basis of above the Company is required to clarify following: 1. Insurance amount claimed and realized by the listed entity for the loss/damage;2. The actual amount of damage caused due to the natural calamity or other force majeure events;3. Details of steps taken to restore normalcy and the impact of the natural calamity/other force majeure events on production or service, financials of the entity.The response of the Company is awaited.
- 14 Mar · Updates
  Disclosure of events or information pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (opens in a new tab)
- 14 Mar · Disclosure Of Events Or Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  As already informed to the stock exchanges, the resolution plan approved by the Committee of Creditors of Sharon Bio-Medicine Limited has already been filed with the Hon'ble National .... (opens in a new tab)
Feb 2023
- 27 Feb · Pursuant To Regulation 30 (4) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, Read With Para B Of Part A Of Schedule III, This Is To Inform You That A Fire Accident Took Place During The Morning Hours On Sunday, February 26, 2023, At The Company'S Manufacturing Unit Located At M/S Sharon Bio-Medicine Limited, Plot No L6, MIDC Area, Taloja , Panvel, Dist: Raigad, Maharashtra
  Read with Para B of Part A of Schedule III, this is to inform you that a fire .... (opens in a new tab)
- 27 Feb · Updates
  Pursuant to Regulation 30 (4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Para B of Part A of Schedule III, this is to inform you that a fire accident took place during the morning hours on Sunday, February 26, 2023, at the Company s manufacturing unit located at M/s Sharon Bio-Medicine Limited, Plot No L6, MIDC Area, Taloja , Panvel, Dist: Raigad, Maharashtra (opens in a new tab)
- 24 Feb
  Updates (opens in a new tab)
  File name: “SubmittedFinancialsResultDecemberQtreditableformat”
- 24 Feb · Legal
  Exchange has sought clarification from Sharon Bio-Medicine Limited with respect to announcement dated 18-Feb-2023, regarding strikes/lockouts/disturbances. On basis of above the Company is required to clarify following: 1. In the event of settlement of the proceedings, details of such settlement including - terms of the settlement, compensation/penalty paid (if any) and impact of such settlement on the financial position of the listed entity.The response of the Company is awaited.
- 18 Feb
  Strikes/lockouts/disturbances (opens in a new tab)
- 18 Feb · Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances
  In furtherance to our corporate announcement dated December 29, 2022, and pursuant to Regulation 30 (7) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, .... (opens in a new tab)
- 10 Feb · Results
  Financial results for the period ended December 31, 2022. (opens in a new tab)
- 10 Feb · Results
  We enclose herewith the Un-audited Financial Results of the Company for the quarter and .... (opens in a new tab)
- 2 Feb · Board meeting
  To consider and approve the financial results for the period ended December 31, 2022 (opens in a new tab)
- 2 Feb · Board meeting
  SHARON BIO-MEDICINE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 ,inter alia, to consider and approve Un-Audited Financial .... (opens in a new tab)
Jan 2023
Dec 2022
- 29 Dec · Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances
  "Dharmarajya-Kamagar Karmachari Mahasangh" a registered trade union in the API Manufacturing Facility of the Company at Taloja, Navi Mumbai has given a call for observance of indefinite .... (opens in a new tab)
- 29 Dec
  Strikes/lockouts/disturbances (opens in a new tab)
- 26 Dec · Updates
  Company is in receipt of advisory letters from NSE and BSE on December 12, 2022, and December 20, 2022, respectively. It is through the advisory letters that the Company noticed the mistake that it had inadvertently missed mentioning the names of the promoters corresponding to their shareholding in the shareholding patterns filed for the quarters ended December 2020 to September 2022. Immediately upon the receipt of the advisory letters, the Company rectified the same by disclosing the names of the promoters and submitted the updated shareholding patterns to the stock exchanges and further uploaded the same on the website of the Company. (opens in a new tab)
- 26 Dec · Rectification In Shareholding Pattern In Response To Advisory Letters Issued By NSE And BSE.
  Company is in receipt of advisory letters from NSE and BSE on December 12, 2022, and December 20, 2022, respectively. It is through the advisory letters that the Company noticed the .... (opens in a new tab)
- 20 Dec · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
  Response to letter received on December 12, 2022 regarding non-compliance with SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 ('LODR Regulation') (opens in a new tab)
- 20 Dec · Updates
  Response to letter received on December 12, 2022 regarding non-compliance withSEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 ( LODR Regulation ) (opens in a new tab)
- 14 Dec · General updates
  Revised Shareholding Pattern from the quarter ended December 2020 to September 2022. (opens in a new tab)
- 5 Dec · Response To Your Mail Dated 17Th November 2022 In The Matter Of Sharon Bio-Medicine Limited
  Dear Madam, This in reference to your mail dated 17th November 2022 confirming whether the company has filed reclassification application under regulation 31A. (opens in a new tab)

How the price met the news

The first session after each announcement, beside the market. Moves to 22 Nov 2013 are on BSE closes, before the company traded on NSE.

That dayAgainst the Nifty 500Market median on that newsFive sessionsFive sessions against the Nifty 500Volume, times usual

29 Aug 2018Board or managers changedup 4.49%+4.6 pts vs Nifty 500market median 0.0% · five sessions +24.7% (+26.5 pts vs Nifty 500) · volume 0.1× usual · The announcement (opens in a new tab)
25 Apr 2018Board or managers changedup 2.97%+3.4 pts vs Nifty 500market median 0.0% · five sessions +1.0% (+0.4 pts vs Nifty 500) · volume 0.8× usual · The announcement (opens in a new tab)
16 Jun 2016Board or managers changeddown 1.60%−0.9 pts vs Nifty 500market median 0.0% · five sessions +22.9% (+22.8 pts vs Nifty 500) · volume 0.4× usual · The announcement (opens in a new tab)
15 Jun 2016Board or managers changedup 0.53%−0.5 pts vs Nifty 500market median 0.0% · five sessions +3.2% (+1.9 pts vs Nifty 500) · volume 0.6× usual
24 Mar 2015Board or managers changeddown 3.03%−2.8 pts vs Nifty 500market median 0.0% · five sessions +2.8% (+3.2 pts vs Nifty 500) · volume 0.6× usual
21 Nov 2014Dividenddown 0.27%−0.9 pts vs Nifty 500market median 0.0% · five sessions +0.9% (+0.3 pts vs Nifty 500) · volume 0.9× usual
22 Nov 2013Dividendup 1.74%+1.7 pts vs Nifty 500market median 0.0% · five sessions +3.9% (+2.3 pts vs Nifty 500) · volume 0.9× usual
18 Nov 2013Dividendup 0.54%−1.4 pts vs Nifty 500market median 0.0% · five sessions −2.7% (−1.9 pts vs Nifty 500) · volume 0.9× usual
12 Nov 2013Dividenddown 0.10%+0.8 pts vs Nifty 500market median 0.0% · five sessions +0.6% (−1.4 pts vs Nifty 500) · volume 1.1× usual
30 Oct 2013Board or managers changedup 0.30%−0.2 pts vs Nifty 500market median 0.0% · five sessions +2.0% (+0.6 pts vs Nifty 500) · volume 1.3× usual

11 earlier announcements

24 Dec 2012Dividendup 4.30%+4.1 pts vs Nifty 500market median 0.0% · five sessions +8.6% (+7.4 pts vs Nifty 500) · volume 0.6× usual
23 Oct 2012Dividenddown 0.59%−0.2 pts vs Nifty 500market median 0.0% · five sessions −0.7% (+1.6 pts vs Nifty 500) · volume 1.0× usual
16 Oct 2012Dividendup 0.01%+0.7 pts vs Nifty 500market median 0.0% · five sessions +0.4% (0.0 pts vs Nifty 500) · volume 2.2× usual
18 Nov 2011Dividenddown 1.00%−0.3 pts vs Nifty 500market median 0.0% · five sessions −3.5% (−0.1 pts vs Nifty 500) · volume 1.0× usual
16 Nov 2011Dividenddown 2.48%−1.7 pts vs Nifty 500market median 0.0% · five sessions −1.6% (+3.4 pts vs Nifty 500) · volume 1.3× usual
25 Oct 2011Dividendup 0.56%−0.8 pts vs Nifty 500market median 0.0% · five sessions +0.5% (−2.6 pts vs Nifty 500) · volume 1.3× usual
19 Oct 2011Dividendup 1.37%−0.4 pts vs Nifty 500market median 0.0% · five sessions +6.4% (+4.5 pts vs Nifty 500) · volume 1.1× usual
24 May 2011Credit ratingup 0.71%+0.5 pts vs Nifty 500market median 0.0% · five sessions −0.5% (−2.5 pts vs Nifty 500) · volume 1.6× usual
7 Dec 2010Dividendup 1.80%+2.3 pts vs Nifty 500market median 0.0% · five sessions −1.1% (+0.9 pts vs Nifty 500) · volume 0.6× usual
6 Dec 2010Dividenddown 1.94%−1.8 pts vs Nifty 500market median 0.0% · five sessions −6.0% (−2.7 pts vs Nifty 500) · volume 1.3× usual
26 Nov 2010Dividenddown 3.03%−1.7 pts vs Nifty 500market median 0.0% · five sessions +3.3% (−0.3 pts vs Nifty 500) · volume 1.0× usual

Sharp moves

The latest 30. 16 of the 30 shown had no filing that day or the next.

MoveAgainst the Nifty 500Times its usual moveVolume, times usualFilings

11 Sep 20173 filingsup 17.72%+17.0 pts vs Nifty 5003.7× its usual move · volume 12.8× usual
8 Sep 2017No filing that day or the nextup 19.70%+19.8 pts vs Nifty 5004.8× its usual move · volume 16.2× usual
7 Sep 2017No filing that day or the nextup 10.92%+10.6 pts vs Nifty 5002.8× its usual move · volume 4.2× usual
7 Jul 2017No filing that day or the nextup 11.48%+11.5 pts vs Nifty 5002.6× its usual move · volume 10.9× usual
6 Jul 2017No filing that day or the nextup 19.61%+19.2 pts vs Nifty 5005.4× its usual move · volume 2.6× usual
3 May 2017No filing that day or the nextup 19.85%+19.9 pts vs Nifty 5008.9× its usual move · volume 4.2× usual
28 Apr 20171 filingdown 10.42%−10.3 pts vs Nifty 5005.8× its usual move · volume 11.6× usual
27 Apr 20173 filingsdown 10.00%−9.9 pts vs Nifty 5007.8× its usual move · volume 7.4× usual
19 Oct 20161 filingup 12.62%+12.7 pts vs Nifty 5002.5× its usual move · volume 0.8× usual
21 Sep 20162 filingsup 19.90%+19.9 pts vs Nifty 5004.8× its usual move · volume 12.8× usual

20 earlier moves

20 Sep 20164 filingsup 19.64%+20.0 pts vs Nifty 5004.8× its usual move · volume 3.6× usual
20 Jul 2016No filing that day or the nextup 15.45%+14.9 pts vs Nifty 5003.4× its usual move · volume 2.6× usual
22 Jun 20162 filingsup 19.69%+19.9 pts vs Nifty 5005.2× its usual move · volume 4.6× usual
1 Jun 2016No filing that day or the nextdown 19.52%−19.7 pts vs Nifty 5005.0× its usual move · volume 10.4× usual
11 Mar 2016No filing that day or the nextdown 11.84%−12.1 pts vs Nifty 5002.7× its usual move · volume 5.8× usual
10 Mar 2016No filing that day or the nextup 18.45%+19.0 pts vs Nifty 5005.1× its usual move · volume 5.2× usual
18 Jan 2016No filing that day or the nextdown 12.33%−10.5 pts vs Nifty 5002.4× its usual move · volume 1.5× usual
11 Dec 20153 filingsup 13.56%+14.5 pts vs Nifty 5003.1× its usual move · volume 8.8× usual
10 Dec 20153 filingsup 14.97%+14.1 pts vs Nifty 5003.7× its usual move · volume 3.7× usual
8 Dec 20153 filingsup 18.62%+19.6 pts vs Nifty 5005.7× its usual move · volume 10.6× usual
19 Aug 2015No filing that day or the nextup 18.27%+18.0 pts vs Nifty 5003.2× its usual move · volume 13.6× usual
18 Aug 20152 filingsup 19.94%+19.8 pts vs Nifty 5003.9× its usual move · volume 3.3× usual
10 Aug 2015No filing that day or the nextup 10.62%+11.0 pts vs Nifty 5002.1× its usual move · volume 1.8× usual
8 Jul 20156 filingsup 10.08%+11.7 pts vs Nifty 5002.1× its usual move · volume 3.1× usual
7 Jul 2015No filing that day or the nextup 19.80%+19.7 pts vs Nifty 5004.5× its usual move · volume 3.6× usual
6 Jul 2015No filing that day or the nextup 13.31%+12.7 pts vs Nifty 5003.3× its usual move · volume 2.5× usual
24 Dec 2014No filing that day or the nextdown 16.32%−15.5 pts vs Nifty 5003.8× its usual move · volume 2.5× usual
15 Dec 2014No filing that day or the nextdown 20.00%−19.8 pts vs Nifty 5006.9× its usual move · volume 1.7× usual
25 Sep 20141 filingdown 10.07%−8.6 pts vs Nifty 5002.3× its usual move · volume 0.6× usual
7 Jul 20141 filingup 14.23%+13.8 pts vs Nifty 5004.8× its usual move · volume 4.4× usual

Last results date

Sharon Bio-Medicine Ltd-$ annual reports, presentations and earnings calls

Annual reports16

Sharon Bio-Medicine Ltd-$ share news and announcements

Feb 2024

Aug 2023

Jun 2023

May 2023

Apr 2023

Mar 2023

Feb 2023

Jan 2023

Dec 2022

How the price met the news

Sharp moves